Detection of the T790M mutation of <i>EGFR</i> in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study)
Takayuki Takahama(Kindai University), Kazuto Nishio(Kindai University)
Cited by 72
Related Papers
Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer
|British Journal of Cancer|2011|110
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
|International Journal of Oncology|2013|91
Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib (“Iressa”)‐sensitive and resistant xenograft models
|Cancer Science|2004|60
Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition
|International Journal of Oncology|2014|56
Overexpression of heparan sulfate 6-O-sulfotransferase-2 in colorectal cancer
|Molecular and Clinical Oncology|2013|38